BP
IMA

BBR Partners’s ImageneBio Inc IMA Stock Holding History

BBR Partners’s Portfolio IMA Stock Details IMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-5,833
Closed -$89.6K – 255
2025
Q1 		$89.6K Hold
5,833
– – 0.01% 232
2024
Q4 		$115K Sell
5,833
-5,000
-46% -$101K 0.01% 237
2024
Q3 		$225K Buy
10,833
+9,166
+550% +$185K 0.02% 209
2024
Q2 		$33K Buy
+1,667
New +$29.4K ﹤0.01% 216

Other funds holding IMA

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

BBR Partners's IMA Position: Q2 2025 in Review

BBR Partners sold out of ImageneBio Inc (IMA) in Q2 2025, closing a stake of 5,833 shares — an estimated $89.6K sold.

BBR Partners first reported a position in IMA in Q2 2024 and held it in 4 quarters. The position peaked at $225K in Q3 2024. 40 funds tracked by Wall St. Rank hold IMA as of Q2 2025.

  • BBR Partners reported no remaining ImageneBio Inc position as of Q2 2025 after selling out during the quarter.
  • BBR Partners sold 5,833 ImageneBio Inc shares in Q2 2025, an estimated $89.6K.
  • BBR Partners first reported a position in ImageneBio Inc in Q2 2024 and held it in 4 quarters.
  • BBR Partners's ImageneBio Inc position peaked at $225K in Q3 2024.
  • 40 funds tracked by Wall St. Rank held ImageneBio Inc as of Q2 2025.

Based on BBR Partners's 13F filing for Q2 2025, filed 14 Aug 2025.